Ramses thank you for sharing and my simplified assessment of the company and view of events as folows:
1 Excellent management and products - 9/10
2 ASX300 inclusion - 6.5/10
3 NASDAQ listing after annual report to ASX/NASDAQ due end of month and therefore expect ann by end of oct - 8/10
4 Positive interim Phase2B update ann before end of year -7/10
5 Dubai sales starts by end of year - 7/10
6 If treatment is successful and sales in Australia/Europe - 9.5/10
7 Completion of Phase3 recruitment - 6.5/10
8 Final FDA approval/worldwide sales - 10/10
Above all IMHO and GL to all SH
Ramses thank you for sharing and my simplified assessment of the...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.005(1.27%) |
Mkt cap ! $581.0M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 41.0¢ | 38.5¢ | $1.351M | 3.389M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16911 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 154170 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |